Pacira BioSciences (PCRX)
(Delayed Data from NSDQ)
$27.21 USD
-0.11 (-0.40%)
Updated May 3, 2024 04:00 PM ET
After-Market: $27.22 +0.01 (0.04%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/7/24 |
---|---|
Current Quarter | 0.64 |
EPS Last Quarter | 0.89 |
Last EPS Surprise | 0.00% |
ABR | 1.30 |
Earnings ESP
|
8.05% |
---|---|
Current Year | 2.94 |
Next Year | 3.68 |
EPS (TTM) | 2.92 |
P/E (F1) | 9.30 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 165.43M | 173.76M | 694.27M | 759.16M |
# of Estimates | 7 | 7 | 8 | 8 |
High Estimate | 174.95M | 175.75M | 705.18M | 782.32M |
Low Estimate | 158.68M | 171.65M | 685.07M | 738.42M |
Year ago Sales | 160.34M | 169.47M | 674.98M | 694.27M |
Year over Year Growth Est. | 3.18% | 2.53% | 2.86% | 9.35% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.64 | 0.74 | 2.94 | 3.68 |
# of Estimates | 7 | 7 | 7 | 7 |
Most Recent Consensus | 0.56 | 0.70 | 2.85 | 3.56 |
High Estimate | 0.80 | 0.83 | 3.32 | 4.13 |
Low Estimate | 0.55 | 0.69 | 2.84 | 3.51 |
Year ago EPS | 0.53 | 0.78 | 2.81 | 2.94 |
Year over Year Growth Est. | 20.75% | -5.13% | 4.63% | 25.22% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 0 | 1 | 2 |
Down Last 30 Days | 1 | 0 | 1 | 2 |
Down Last 60 Days | 3 | 2 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.64 | 0.74 | 2.94 | 3.68 |
7 Days Ago | 0.65 | 0.74 | 2.95 | 3.71 |
30 Days Ago | 0.65 | 0.74 | 2.95 | 3.71 |
60 Days Ago | 0.70 | 0.77 | 3.12 | 3.92 |
90 Days Ago | 0.79 | 0.87 | 3.51 | 4.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.69 | 0.74 | 2.90 | 3.54 |
Zacks Consensus Estimate | 0.64 | 0.74 | 2.94 | 3.68 |
Earnings ESP | 8.05% | 0.00% | -1.31% | -3.80% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.89 | 0.72 | 0.78 | 0.53 | NA |
Estimate | 0.89 | 0.84 | 0.81 | 0.60 | NA |
Difference | 0.00 | -0.12 | -0.03 | -0.07 | -0.06 |
Surprise | 0.00% | -14.29% | -3.70% | -11.67% | -7.42% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more